SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration

Disclosure: S. Rojekar: None. A.R. Pallapati: None. J. Gimenez–Roig: None. D. Sant: None. S. Gera: None. F. Korkmaz: None. F. Sultana: None. O. Barak: None. O. Moldavski: None. U. Cheliadinova: None. A. Gumerova: None. S. Miyashita: None. H.S. Kannangara: None. T. Frolinger: None. R. Witztum: None....

Descripción completa

Detalles Bibliográficos
Autores principales: Rojekar, Satish, Pallapati, Anusha Rani, Gimenez–Roig, Judit, Sant, Damini, Gera, Sakshi, Korkmaz, Funda, Sultana, Farhath, Barak, Orly, Moldavski, Ofer, Cheliadinova, Uliana, Gumerova, Anisa Azatovna, Miyashita, Sari, Kannangara, Hasni Suhasha, Frolinger, Tal, Witztum, Ronit, Macdonald, Anne, Georgii, Pevnev, Sims, Steven Lee, Caminis, John N, Meseck, Marcia, Ryu, Vitaly, Kim, Se-Min, Lizneva, Daria, Yuen, Tony, Zaidi, Mone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554797/
http://dx.doi.org/10.1210/jendso/bvad114.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554797/
http://dx.doi.org/10.1210/jendso/bvad114.117

Ejemplares similares